Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 242.4 INR -3.73%
Market Cap: 5.5B INR
Have any thoughts about
Jenburkt Pharmaceuticals Ltd?
Write Note

Jenburkt Pharmaceuticals Ltd
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jenburkt Pharmaceuticals Ltd
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jenburkt Pharmaceuticals Ltd
BSE:524731
Total Assets
â‚ą1.8B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
12%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Assets
â‚ą467.3B
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Assets
â‚ą346.6B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Assets
â‚ą881.2B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
11%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Assets
â‚ą150.9B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Assets
â‚ą119.6B
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jenburkt Pharmaceuticals Ltd
Glance View

Market Cap
5.5B INR
Industry
Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The company is headquartered in Mumbai, Maharashtra and currently employs 730 full-time employees. The firm offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The firm's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The firm's manufacturing plant is located in Sihor-Gujarat. The firm's products are exported to approximately 13 countries globally.

JENBURPH Intrinsic Value
785.72 INR
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Jenburkt Pharmaceuticals Ltd's Total Assets?
Total Assets
1.8B INR

Based on the financial report for Sep 30, 2024, Jenburkt Pharmaceuticals Ltd's Total Assets amounts to 1.8B INR.

What is Jenburkt Pharmaceuticals Ltd's Total Assets growth rate?
Total Assets CAGR 10Y
12%

Over the last year, the Total Assets growth was 21%. The average annual Total Assets growth rates for Jenburkt Pharmaceuticals Ltd have been 12% over the past three years , 12% over the past five years , and 12% over the past ten years .

Back to Top